We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Tyco to Split Into Three Companies

By HospiMedica staff writers
Posted on 25 Jan 2006
A plan to separate the firm's current portfolio of diverse businesses into three separate, publicly traded companies has been announced by Tyco International Ltd. More...
(Pembroke, Bermuda).

The three businesses are Tyco Healthcare, Tyco Electronics, and Tyco Fire & Security and Engineered Products & Services. Tyco intends to accomplish the separation through tax-free stock dividends to shareholders, after which they will own 100% of the equity in the three publicly traded companies. Each company will have its own independent board of directors and strong corporate governance standards. Tyco intends to complete these transactions during the first quarter of 2007.

Tyco's board and senior leadership evaluated a broad range of strategic alternatives, including continuation of Tyco's current operating strategy, the sales of select businesses, and separation of only one of the businesses. However, they concluded that separating into three businesses would be the best way to position the companies for sustained growth and value creation.

With 2005 revenue of nearly U.S.$10 billion, Tyco Healthcare is an important global provider of healthcare products and services. Its product portfolio includes advanced surgical instruments and supplies, respiratory care products, contrast media and diagnostic imaging products, needles and syringes, vascular therapies, sutures, wound-care products, and generic pharmaceuticals.

The separation will create a stand-alone healthcare company that is expected to benefit from a focused and independent healthcare culture to help attract top industry talent and strategic partners as well as increase access to emerging healthcare-related technologies. This business will continue to be led by the current president of Tyco Healthcare, Rich Meelia, who will become the company's chief executive officer.

Tyco anticipates that all three companies will be capitalized to provide financial flexibility to take advantage of future growth opportunities. The companies are expected to have financial policies, balance sheets, and credit metrics that are commensurate with solid investment-grade credit ratings.




Related Links:
Tyco

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.